Hunan Haili Chemical Industry Co., Ltd. (600731.SS)
CNY 6.08
(-0.82%)
CNY 6.08
(-0.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 409.85 Million | 249.08 Million | 121.94 Million | 459.06 Million | 200.43 Million | 115.98 Million |
| Net Income | 283.92 Million | 374.46 Million | 289.11 Million | 300.65 Million | 110.67 Million | 77.72 Million |
| Depreciation & Amortization | 92.46 Million | 83.03 Million | 60.36 Million | 48.05 Million | 166.05 Million | 54.78 Million |
| Deferred income taxes | -11.13 Million | -2.62 Million | -3.4 Million | 3.48 Million | -1.04 Million | -73.99 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 76.79 Million | -239.88 Million | -261.86 Million | 52.98 Million | -104.44 Million | -104.21 Million |
| Other non-cash items | -43.32 Million | 31.47 Million | 34.32 Million | 57.37 Million | 28.14 Million | 87.7 Million |
| Investing Cash Flow | -382.13 Million | -313.53 Million | -85.73 Million | -340.23 Million | -67.64 Million | -46.69 Million |
| Investments in PPE | -383.24 Million | -321.09 Million | -184.61 Million | -263.12 Million | -98.19 Million | -87.1 Million |
| Acquisitions | -481.46 Thousand | 9.32 Million | 5.93 Million | 273.64 Million | 28.64 Million | 38.36 Million |
| Investment purchases | 5.67 Million | -2 Million | -5.93 Million | -90 Million | -28.64 Million | - |
| Sales/Maturities of investments | 232.44 Thousand | 232.44 Thousand | 92.94 Million | 2.36 Million | 1.9 Million | 2.04 Million |
| Other Investing Activities | -4.31 Million | 1.09 | 5.93 Million | -263.12 Million | 28.64 Million | 38.36 Million |
| Financing Cash Flow | 291.6 Million | 349.37 Million | -439.81 Million | 231.63 Million | -103.78 Million | 101.85 Million |
| Debt repayment | -264.5 Million | -412.26 Million | -647.6 Million | -644.9 Million | -616.5 Million | -427.5 Million |
| Dividends payments | -21.25 Million | -16.81 Million | -85.25 Million | -16.19 Million | -38.13 Million | -27.8 Million |
| Common Stock Repurchased | - | -105.69 Million | -27.85 Million | - | - | - |
| Common Stock Issuance | - | 105.69 Million | 27.85 Million | - | - | - |
| Other Financing Activities | 587.18 Million | 788.18 Million | 251.35 Million | 900.75 Million | 550.85 Million | 557.16 Million |
| Accounts receivables | 157.72 Million | -53.37 Million | -380.83 Million | -83.59 Million | -121.92 Million | -122.54 Million |
| Accounts payables | -54.43 Million | -59.16 Million | 195.27 Million | -12.23 Million | 86.96 Million | 56.83 Million |
| Inventory | -15.36 Million | -124.71 Million | -73.37 Million | 105.27 Million | -68.43 Million | -38.43 Million |
| Other working capital | -11.13 Million | -2.62 Million | -2.93 Million | 43.53 Million | -1.04 Million | -65.78 Million |
| Cash at beginning of period | 737.67 Million | 452.55 Million | 830.14 Million | 442.12 Million | 413.12 Million | 241.94 Million |
| Cash at end of period | 1.05 Billion | 737.67 Million | 426.53 Million | 792.59 Million | 442.12 Million | 413.12 Million |
| Capital Expenditure | -383.24 Million | -321.09 Million | -184.61 Million | -263.12 Million | -98.19 Million | -87.1 Million |
| Effect of forex changes on cash | 10.25 Thousand | 190.66 Thousand | 277.21 | 2384.18 | 1257.48 | 22.86 Thousand |
| Net cash flow / Change in cash | 319.33 Million | 285.12 Million | -403.6 Million | 350.47 Million | 29 Million | 171.17 Million |
| Free Cash Flow | 26.61 Million | -72 Million | -62.66 Million | 195.94 Million | 102.24 Million | 28.88 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 91.45 Million | 9.69 Million | 283.92 Million | 29.39 Million | 81.28 Million |
| Depreciation & Amortization | - | 26 Million | 26 Million | 92.46 Million | 22.34 Million | -47.77 Million |
| Deferred income taxes | - | - | - | -11.13 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -173.37 Million | - | 76.79 Million | 141.77 Million | -107.23 Million |
| Other non-cash items | - | 21.26 Million | -173.57 Million | -43.32 Million | -158.24 Million | 138.7 Million |
| Investing Cash Flow | -43.51 Million | -37.1 Million | -60.9 Million | -382.13 Million | -105.38 Million | -131.29 Million |
| Investments in PPE | -43.69 Million | -37.1 Million | -60.94 Million | -383.24 Million | -111.26 Million | -128.95 Million |
| Acquisitions | - | - | 44.96 Thousand | -481.46 Thousand | 4.52 Million | 657.59 Thousand |
| Investment purchases | - | - | - | 5.67 Million | - | - |
| Sales/Maturities of investments | - | - | - | 232.44 Thousand | - | - |
| Other Investing Activities | 182.11 Thousand | 258.08 Thousand | 44.96 Thousand | -4.31 Million | 1.34 Million | -2.99 Million |
| Financing Cash Flow | -16.27 Million | -133.54 Million | -4.53 Million | 291.6 Million | -119.58 Million | 9.81 Million |
| Debt repayment | - | -2.5 Million | -1 Million | -264.5 Million | -109.7 Million | - |
| Dividends payments | -4.53 Million | -115.62 Million | -3.82 Million | -21.25 Million | -3.89 Million | -5.99 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -11.74 Million | -131.04 Million | -3.53 Million | 587.18 Million | 4.83 Million | 15.81 Million |
| Accounts receivables | - | -143.04 Million | - | 157.72 Million | 157.72 Million | -170.02 Million |
| Accounts payables | - | - | - | -54.43 Million | - | 3.06 Million |
| Inventory | - | -32.67 Million | - | -15.36 Million | -15.36 Million | 62.79 Million |
| Other working capital | - | 2.34 Million | - | -11.13 Million | -588.13 Thousand | -3.06 Million |
| Cash at beginning of period | 743.76 Million | 832.01 Million | 1.06 Billion | 737.67 Million | 1.24 Billion | 1.3 Billion |
| Cash at end of period | 887.37 Million | 764.19 Million | 832.01 Million | 1.05 Billion | 1.05 Billion | 1.24 Billion |
| Capital Expenditure | -43.69 Million | -37.1 Million | -60.94 Million | -383.24 Million | -111.26 Million | -128.95 Million |
| Effect of forex changes on cash | 2837.50 | 1497.00 | - | 10.25 Thousand | 16.25 Thousand | 1.38 |
| Net cash flow / Change in cash | 143.6 Million | -67.81 Million | -229.56 Million | 319.33 Million | -189.69 Million | -56.48 Million |
| Free Cash Flow | -43.69 Million | 49.61 Million | -224.82 Million | 26.61 Million | -75.99 Million | -63.96 Million |
RIDDHICORP
SGD
3349
EM
LAVV3
MEDS